-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,772.55(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Astec Lifesciences Ltd Pesticides / Agrochemicals - Indian
- Godrej
- BSE Code : 27594.0
- ISIN : INE563J01010
-
Today’s Low
702.35 -
Today’s High
747.75

-
Open
739.00 -
Perv Close
739.00 -
52W Low
647.50 -
52W High
1,474.40
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
1,391.72
-
Div & Yield %
0.00
-
Book Value(₹)
119.35
-
Debt-Equity Ratio
-3.97
-
AGM Date
25-Apr-2025
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
1.06
-
Mar.Cap (₹Cr.)
1,391.72
-
RONW (%)
-11.89
-
ROCE (%)
-4.49
Score Board
-
Equity (₹ in Cr.)
19.61
-
BV (₹)
119.40
-
Sales( ₹ in Cr.)
381.30
-
NP (in Cr.)
-134.81
-
NP Var(%)
-188.0
-
Div%
0.0
-
CPS (₹)
-46.40
-
EPS (₹)
-68.70
-
Traded Value (₹ in Lakhs)
1,449.38
-
52 Week High
1,474.40
-
52 Week Low
647.50
-
Price BSE
739.0
-
Price NSE
739.00
-
Market Capital( in Cr.)
1,449.38
-
P/C Ratio
-15.90
-
P/E Ratio
-10.80
-
Price Vs.BV
-68.70
-
24-Apr-2025( 09:10)
Corporate News - Astec... - Astec Lifesciences announced t...
-
24-Apr-2025( 07:36)
Results - Announcements - Astec... - Net Loss of Astec Lifesciences...
-
24-Apr-2025( 01:24)
Hot Pursuit - Astec... - Revenue from operations declin...
-
16-Apr-2025( 01:58)
Corporate News - Astec... - Astec Lifesciences will hold a...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 458.18 | 628.17 | 676.57 | 554.87 | 522.22 | 430.90 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 458.18 | 628.17 | 676.57 | 554.87 | 522.22 | 430.90 |
Other Income | 5.58 | 13.04 | 10.46 | 7.67 | 11.93 | 11.10 |
Stock Adjustments | -0.46 | 59.59 | 58.00 | 2.55 | -4.73 | 15.56 |
Total Income | 463.30 | 700.80 | 745.03 | 565.09 | 529.42 | 457.56 |
EXPENDITURE : | ||||||
Raw Materials | 318.82 | 460.83 | 444.82 | 344.60 | 333.44 | 295.05 |
Power and Fuel Cost | 35.87 | 45.68 | 38.04 | 25.28 | 28.80 | 23.80 |
Employee Cost | 61.74 | 52.26 | 50.31 | 38.35 | 29.92 | 25.10 |
Other Manufacturing Expenses | 15.81 | 16.46 | 13.37 | 11.70 | 5.18 | 5.00 |
Selling and Administration Expenses | 20.97 | 25.76 | 23.54 | 17.16 | 21.79 | 15.47 |
Miscellaneous Expenses | 10.42 | 10.50 | 10.40 | 8.83 | 13.16 | 5.63 |
Employee Benefit Expenses | 61.74 | 52.26 | 50.31 | 38.35 | 29.92 | 25.10 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 463.62 | 611.49 | 580.49 | 445.92 | 432.29 | 370.05 |
Operating Profit | -0.32 | 89.30 | 164.55 | 119.18 | 97.14 | 87.51 |
Interest | 25.24 | 20.74 | 9.09 | 4.79 | 12.64 | 12.38 |
Gross Profit | -25.56 | 68.56 | 155.46 | 114.39 | 84.50 | 75.13 |
Depreciation | 36.31 | 33.71 | 34.42 | 25.71 | 23.22 | 19.34 |
Profit Before Tax | -61.87 | 34.85 | 121.04 | 88.68 | 61.28 | 55.79 |
Current Tax | 0.00 | 0.00 | 28.61 | 24.59 | 16.86 | 15.69 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -14.89 | 9.33 | 2.61 | -0.61 | -3.05 | 4.42 |
Reported Net Profit | -46.99 | 25.52 | 89.82 | 64.69 | 47.47 | 35.69 |
Extraordinary Items | -0.11 | -0.38 | 0.01 | -0.05 | -0.13 | 0.00 |
Adjusted Net Profit | -46.88 | 25.90 | 89.81 | 64.74 | 47.60 | 35.69 |
Adjustment below Net Profit | -0.57 | -0.23 | -0.01 | -0.18 | -0.84 | -0.65 |
P & L Balance brought forward | 325.60 | 303.25 | 216.37 | 154.79 | 111.09 | 78.99 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 2.94 | 2.94 | 2.94 | 2.94 | 2.93 | 2.93 |
P & L Balance carried down | 275.10 | 325.60 | 303.25 | 216.37 | 154.79 | 111.09 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 |
Dividend Per Share(Rs) | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
Earnings Per Share-Unit Curr | -23.96 | 13.02 | 45.83 | 33.03 | 24.26 | 18.25 |
Earnings Per Share(Adj)-Unit Curr | -23.96 | 13.02 | 45.83 | 33.03 | 24.26 | 18.25 |
Book Value | 188.01 | 213.61 | 202.06 | 157.60 | 125.94 | 103.55 |
Book Value(Adj)-Unit Curr | 188.01 | 213.61 | 202.06 | 157.60 | 125.94 | 103.55 |